The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence
- 1 January 2007
- journal article
- Published by Cold Spring Harbor Laboratory in Genes & Development
- Vol. 21 (1), 43-48
- https://doi.org/10.1101/gad.1487307
Abstract
Here we report that RNA interference against ATM inhibited p53 accumulation in cells expressing oncogenic STAT5 and cooperated with Rb inactivation to suppress STAT5A-induced senescence. Knocking down ATM was also effective to bypass E2F1-induced senescence and in combination with Rb inactivation, inhibited RasV12-induced senescence. Cells that senesced in response to ca-STAT5A or RasV12 accumulated DNA damage foci and activated ATM, ATR, Chk1, and Chk2, indicating that aberrant oncogene activation induces a DNA damage signaling response. Intriguingly, bypassing oncogene-induced senescence by inactivation of p53 and Rb did not eliminate the accumulation of oncogene-induced DNA damage foci (ODDI), suggesting a mechanism that may limit transformation in immortalized cells.Keywords
This publication has 43 references indexed in Scilit:
- Activation of the DNA damage checkpoint and genomic instability in human precancerous lesionsNature, 2005
- DNA damage response as a candidate anti-cancer barrier in early human tumorigenesisNature, 2005
- Intrinsic tumour suppressionNature, 2004
- High Intensity ras Signaling Induces Premature Senescence by Activating p38 Pathway in Primary Human FibroblastsJournal of Biological Chemistry, 2004
- A DNA damage checkpoint response in telomere-initiated senescenceNature, 2003
- DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociationNature, 2003
- 53BP1 functions in an ATM-dependent checkpoint pathway that is constitutively activated in human cancerNature Cell Biology, 2002
- Role of p14ARF in Replicative and Induced Senescence of Human FibroblastsMolecular and Cellular Biology, 2001
- STATs in oncogenesisOncogene, 2000
- Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4aCell, 1997